Back
Nektar Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
NKTR
Nektar Therapeutics
Last Price:
1.02
Seasonality Move:
15.74%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Nektar Therapeutics Price Quote
$1.02
+0.01 (+2%)
(Updated: November 22, 2024 at 4:02 AM ET)
Nektar Therapeutics Key Stats
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Day range:
$0.98 - $1.04
52-week range:
$0.42 - $1.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.18
P/B ratio:
3.81%
Volume:
1.5M
Avg. volume:
1.7M
1-year change:
114.89%
Market cap:
$186.3M
Revenue:
$90.1M
EPS:
$-0.84
How Much Does Nektar Therapeutics Make?
-
How Much Are Nektar Therapeutics's Sales Annually?
NKTR Revenues are $90.1M -
How Much Profit Does Nektar Therapeutics's Make A Year?
NKTR net income is -$276.1M
Is Nektar Therapeutics Growing As A Company?
-
What Is Nektar Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0% -
What Is Nektar Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Nektar Therapeutics Stock Price Performance
-
Did Nektar Therapeutics Stock Go Up Last Month?
Nektar Therapeutics share price went down by -27.34% last month -
Did NKTR's Share Price Rise Over The Last Year?
NKTR share price rose by 114.89% over the past 1 year
What Is Nektar Therapeutics 52-Week High & Low?
-
What Is Nektar Therapeutics’s 52-Week High Share Price?
Nektar Therapeutics has traded as high as $1.93 over the past 52 weeks -
What Is Nektar Therapeutics’s 52-Week Low Share Price?
Nektar Therapeutics has traded as low as $0.42 over the past 52 weeks
Nektar Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Nektar Therapeutics?
-
How Much Debt Does Nektar Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Nektar Therapeutics Have?
Cash and short term investments quarterly total is $244.5M -
What Is Nektar Therapeutics’s Book Value Per Share?
Book value per share is 0.27
Is Nektar Therapeutics Cash Flow Positive?
-
What Is NKTR Cash Flow From Operations?
Cash flow from operations (TTM) is -$176.6M -
What Is Nektar Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $42M -
What Is Nektar Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $99.7M
Nektar Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NKTR return on invested capital is -154.23% -
What Is Nektar Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -44.58% -
What Is NKTR Return On Equity?
ROE is a measure of profitability and is -154.23%
Nektar Therapeutics Earnings Date & Stock Price
-
What Is Nektar Therapeutics's Stock Price Today?
A single share of NKTR can be purchased today for 1.01 -
What Is Nektar Therapeutics’s Stock Symbol?
Nektar Therapeutics trades on the nasdaq under the ticker symbol: NKTR -
When Is Nektar Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Nektar Therapeutics is scheduled on March 4, 2025 -
When Is NKTR's next ex-dividend date?
Nektar Therapeutics's next ex-dividend date is November 22, 2024 -
How To Buy Nektar Therapeutics Stock?
You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Nektar Therapeutics Competitors
-
Who Are Nektar Therapeutics's Competitors?
Below is a list of companies who compete with Nektar Therapeutics or are related in some way:
Nektar Therapeutics Dividend Yield
-
What Is NKTR Dividend Yield?
Nektar Therapeutics’s dividend yield currently is 0% -
What Is Nektar Therapeutics’s Payout Ratio?
Nektar Therapeutics’s payout ratio is 0% -
When Did Nektar Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Nektar Therapeutics’s Dividend Per Share?
Nektar Therapeutics pays a dividend of $0.00 per share
Nektar Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 14.26% |
| Revenue: | -0.08% | 31.97% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 4.10 |
| Upside from Last Price: | 305.94% |